Loading...
Documents
-
Angeline Ginzac, Ioana Molnar, Xavier Durando, Thibault de La Motte Rouge, Thierry Petit, et al.. Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial. Breast Cancer Research and Treatment, 2024, ⟨10.1007/s10549-024-07285-y⟩. ⟨hal-04495069⟩
-
Pénélope Desroys Du Roure, Laurie Lajoie, Aude Mallavialle, Lindsay Alcaraz, Hanane Mansouri, et al.. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for Immunotherapy of Cancer, 2024, 12 (1), pp.e007135. ⟨10.1136/jitc-2023-007135⟩. ⟨hal-04459385⟩
-
Enora Dolivet, Léopold Gaichies, Corinne Jeanne, Céline Bazille, Mélanie Briand, et al.. Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors. International Journal of Molecular Sciences, 2023, International Journal of Molecular Sciences, 24 (21), pp.16016. ⟨10.3390/ijms242116016⟩. ⟨hal-04481385⟩
-
Léo Plaçais, Stéphane Dalle, Olivier Dereure, Sabiha Trabelsi, Sophie Dalac, et al.. Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control study. Annals of the Rheumatic Diseases, 2022, 81 (10), pp.1445-1452. ⟨10.1136/ard-2022-222186⟩. ⟨hal-04079755⟩
-
Abderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, Jérémie H Lefèvre, Magali Svrcek, et al.. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. International Journal of Cancer, 2024, International Journal of Cancer, 154 (3), pp.504-515. ⟨10.1002/ijc.34781⟩. ⟨hal-04304405⟩
-
Valentin Flaudias, Corentin Gonthier, Marie Christine Picot, Pierre-Michel Llorca, Audrey Schmitt, et al.. Neuropsychological assessment fails to predict relapse among cigarette smokers: A prospective study of neurocognitive abilities. Addictive Behaviors, 2024, 151, pp.107940. ⟨10.1016/j.addbeh.2023.107940⟩. ⟨hal-04383364⟩
-
Stéphane Culine, Valentin Harter, Gwenaelle Gravis, Aude Fléchon, Christine Chevreau, et al.. Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial. Clinical Genitourinary Cancer, 2021, 19 (6), pp.554-562. ⟨10.1016/j.clgc.2021.08.005⟩. ⟨hal-03625944⟩
-
Nicolas Kerckhove, Jérôme Busserolles, Trevor Stanbury, Bruno Pereira, Valérie Plence, et al.. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup. BMJ Open, 2019, 9 (6), pp.e027770. ⟨10.1136/bmjopen-2018-027770⟩. ⟨hal-02325112⟩